Feng Chi Biotech Corp. announced earnings results for the full year ended December 31, 2019. For the full year, the company announced sales was TWD 174.328 million compared to TWD 148.082 million a year ago. Operating income was TWD 20.098 million compared to TWD 18.717 million a year ago. Net income was TWD 17.358 million compared to TWD 16.805 million a year ago. Basic earnings per share was TWD 1.16 compared to TWD 1.3 a year ago.